See feature articles below:

About Broad Street Alerts:
Big opportunities in Small Cap’s

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
–Report on:(Nasdaq:LINE )

Linn Energy LLC (NASDAQ:LINE) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, April 27th. Analysts expect Linn Energy to post earnings of ($0.01) per share for the quarter.

Linn Energy (NASDAQ:LINE) last issued its earnings results on Tuesday, March 15th. The company reported ($7.05) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.14 by $7.19. The business earned $647 million during the quarter, compared to analysts’ expectations of $747.90 million. The company’s quarterly revenue was down 70.6% on a year-over-year basis. During the same period last year, the firm posted ($0.47) earnings per share. On average, analysts expect Linn Energy to post $0.1100 EPS for the current fiscal year and $-1.0000 EPS for the next fiscal year.

LINE has been the subject of several analyst reports. Wells Fargo lowered Linn Energy from a “market perform” rating to an “underperform” rating in a research note on Thursday, February 18th. Zacks Investment Research raised Linn Energy from a “hold” rating to a “buy” rating and set a $1.50 price objective for the company in a research note on Saturday, January 30th. Ladenburg Thalmann lowered Linn Energy from a “neutral” rating to a “sell” rating in a research note on Friday, February 5th. Raymond James lowered Linn Energy from a “market perform” rating to an “underperform” rating in a research note on Friday, February 5th. Finally, Stifel Nicolaus lowered Linn Energy from a “hold” rating to a “sell” rating in a research note on Friday, February 5th. Nine equities research analysts have rated the stock with a sell rating, four have assigned a hold rating, one has given a buy rating and two have given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $6.12.

Shares of Linn Energy LLC (NASDAQ:LINE) traded up 14.6382% on Tuesday, reaching $0.3485. The company’s stock had a trading volume of 7,088,235 shares. Linn Energy LLC has a 12 month low of $0.26 and a 12 month high of $14.21. The firm’s 50-day moving average price is $0.59 and its 200-day moving average price is $1.33. The stock’s market cap is $123.73 million.

Linn Energy, LLC (NASDAQ:LINE) is an oil and natural gas company. The Company is focused on acquiring, developing and maximizing cash flow from a portfolio of oil and natural gas assets. The Company’s properties are located in the United States, in the Rockies, the Hugoton Basin, California, east Texas and north Louisiana (TexLa), the Mid-Continent, the Permian Basin, Michigan/Illinois and south Texas.

Source: American Banking and Market News
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.

See feature articles below:

About Broad Street Alerts:
Big opportunities in Small Cap’s

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
–Report on:(Nasdaq: LGCY )

Investors will be waiting to see if the company hits or misses earnings projections after the next earnings release. Legacy Reserves LP (NASDAQ:LGCY) is slated to next post quarterly results on or around 2016-05-04. The company most recently reported earnings of $-0.33 against the Zacks Research consensus estimate of $-0.38 for the period ending on 2016-03-31. The result created a surprise factor of 13.16%, a difference of $0.05. A large surprise factor may trigger significant stock price swings immediately after an earnings report, or in the following days and weeks. As the next earnings date approaches, analysts may modify their models based on company announcements and Street sentiment. These have the ability be key indicators looking at whether results will meet or beat consensus projections.

Adding in past earnings trends, future earnings predictions and company issued and projected guidance, many covering analysts will also project future target numbers for the stocks they are tracking. These reports are sent to institutions to help assist with making investment decisions. These numbers are also available through different platforms to retail investors. As of this writing, the consensus price target (1 year) on shares of Legacy Reserves LP (NASDAQ:LGCY) stands at $1. This is based on 4 covering analysts tracked by Zacks Research. The analyst with the most positive view has the stock hitting $1, while the lowest target projection sees the stock hitting $1.

Checking on recommendations, 0 analysts have rated the stock a Strong Buy, 0 have rated it a Buy rating, 5 a Hold and 1 a Sell. All of these recommendations can be placed on a ratings scale from 1 to 5 to get to an average broker rating. A low number (1-2) indicates a consensus Buy, a middle number (2.5-3.5) indicates a Hold and any number over 4 would indicate a consensus Sell rating. At the time of writing Legacy Reserves LP shares have a consensus rating of 3.43.

Source: Franklin Independent
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.

See feature articles below:

About Broad Street Alerts:
Big opportunities in Small Cap’s

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 

Article for CPRX

Will there be a bounce for $CPRX after the drastic crash in the share price? This article details the reasons for the price drop but may offer some reason for a near term bounce.

Catalyst Pharmaceuticals CPRX stock crashed over 50% after the company announced that the FDA has requested additional data in its resubmission of a new drug application for Firdapse, a treatment for Lambert-Eaton myasthenic syndrome.

In February, Catalyst hits a major obstacle when it received a “refusal-to-file” letter from the FDA. The regulatory agency determined that Catalyst had not submitted sufficient information for it to complete a preliminary review of Firdapse.

The FDA has now stated that Catalysts needs to submit not one, but two sets of positive results from a studies of patients with Lambert-Eaton myasthenic syndrome. The company will also needs to conduct several toxicology studies.

The issue with these new studies, aside from the fact that Catalyst’s portfolio of approved drugs remains empty, is that they are often very costly and time consuming.

“We are surprised with the FDA’s request for an additional clinical study for Firdapse, but are encouraged that the agency is open to an efficient, small short-term study design. We are currently in discussions with the FDA, and our clinical experts regarding the protocol and logistics for this confirmatory study,” said Catalyst CEO Patrick J. McEnany.

Just 10 days ago, Catalyst reported its fourth-quarter 2015 earnings, posting a loss of 7 cents on R&D expenses that were up over 60% year-over-year. More time and money researching Firdapse is simply something that Catalyst cannot afford right now.

Source – Zacks
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.

See feature articles below:

About Broad Street Alerts:
Big opportunities in Small Cap’s

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

Article for

 

NEW YORK, NY / ACCESSWIRE / April 27, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. MWOG, ASTI, TPIV and PPCH are on high volume watch, particularly MWOG. Continue reading to find out why these stocks are getting so much interest today.

Midwest Oil and Gas Inc. (OTCBB: MWOG) Is an exploration stage company that engages in the exploration, development, and production of onshore oil and natural gas reserves.

Shares of MWOG are trading higher by over 600% pre-market this morning and is showing a $0.39 cent gap in share price from its previous close. After the market opened, the stock doubled from its pre-market high and is now trading higher by almost 1,300%.

The stock is bringing in a lot of volume compared to its average volume and this extra attention probably won’t go unnoticed.

Ascent Solar Technologies, Inc. (NASDAQ: ASTI) Is a development stage company that designs and manufactures photovoltaic integrated consumer electronics; and portable power applications for commercial and military users.

Shares of ASTI have been relatively stagnant in April and appear to be trending lower. After a big day in mid march, the stock has continued a trend of downward action.

As volume continues to get lighter on this stock, chances are it will continue to drop, however, the stock is known to have big short-term bursts in share price and volume.

TapImmune, Inc. (OTCQB: TPIV) Is a clinical-stage immunotherapy company that develops peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and infectious diseases.

Shares of TPIV traded higher yesterday off heavier than usual volume after AstraZeneca announced that they were increasing their immune-oncology with TPIV.

A joint AstraZeneca-TapImmune Phase 2 ovarian cancer trial will start this quarter at the prestigious Sloan Kettering Institute, according to a press release issued a few days ago.

We are watching TPIV to see if it can hold on to and build off of yesterday’s gains.
Propanc Health Group Corporation (OTCQB: PPCH) Is a development stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic and colorectal cancer in Australia.

Shares of PPCH traded higher yesterday by over 16% and the stock has been on a steady rise ever since announcing last week that it had filed two more patent applications in the United States regarding new compositions of its lead product, PRP, for treating cancer.

In early March, PPCH received an influx of share volume that pushed the stock higher by 500%. PPCH received a similar amount of volume the last few trading periods and it is looking like that kind of momentum could continue throughout the rest of the week.

Source – OTC Expert
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.

See feature articles below:

About Broad Street Alerts:
Big opportunities in Small Cap’s

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.

 
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 

AMRS big announcement today

 

Amyris (NASDAQ: AMRS) announced that it has executed a five year Biofene® supply agreement with a global nutraceuticals company. This new, long-term agreement replaces the parties’ one-year purchase agreement, which was previously announced on January 4, 2016. Under the new supply agreement, the customer has agreed to a larger Biofene purchase in 2016 with an expected revenue contribution of approximately $9 million and to minimum annual purchase commitments in each of the remaining years of the agreement. In addition, under the new agreement, Amyris is entitled to a quarterly value-share arrangement on the sales of the customer’s product made from the purchased Biofene. Amyris expects total revenue from the five-year agreement to be more than $100 million. In year-five of the supply agreement term, the agreement is projected to generate approximately $40 million of annual revenue, which Amyris expects will be renewed at that level in subsequent years.

Due to the competitive nature of this market, both parties have agreed to keep the targeted product and the customer’s name confidential.

“This agreement represents a new highly disruptive partner application for our flexible Biofene ingredient ─ which supports multiple broad-based market applications and further solidifies Amyris’s track record of helping solve partners’ supply and product margin needs by supplying cost-advantaged renewable ingredients that perform better than current supply sources,” said John Melo, President & CEO of Amyris. “We are experiencing significant growth in demand for our Biofene and Biofene-derivative applications from large markets such as tires, industrial lubricants, solvents, and nutraceuticals. This demand growth is accelerating our mission to make renewable products mainstream while making our company sustainable.”

 

source-streetinsider
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.